Biomarkers Trajectories of Early Intervention in Siblings of Children With Autism Spectrum Disorder

Sponsor
IRCCS Eugenio Medea (Other)
Overall Status
Recruiting
CT.gov ID
NCT05614206
Collaborator
(none)
80
1
4
24
3.3

Study Details

Study Description

Brief Summary

This project deals with essential challenges in the context of Autism Spectrum Disorder benefiting from a prospective design in childhood, early intervention and a cutting-edge experimental techniques. The present study tests the potential effect of early intervention on neural and behavioral responses in toddlers at elevated likelihood of developing autism (siblings of children with autism) who show clinical autistic signs. Four comparison groups were included in the study: (1) toddlers at elevated likelihood of developing autism with clinical autistic signs who receive early intervention from 18 to 24 months (2) toddlers at elevated likelihood of developing autism with clinical autistic signs who do not receive early intervention (3) toddlers at elevated likelihood of developing autism without clinical autistic signs who only received assessment and monitoring, and (4) typically developing toddlers who only received assessment and monitoring.

This study focuses on social and nonsocial sensory integration skills (measured by electroencephalographic and eyetracking recordings) to identify reliable biomarkers for early detection and intervention of autism during a critical period of development.

The characterization of biomarkers will guide the detection of the most vulnerable children that will benefit from early intervention, with the long-term aim of reducing the impact of autism on the National Health System.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Behavioral intervention based on Applied Behavior Analysis principles
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
80 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Biomarkers Trajectories of Early Intervention in Siblings of Children With Autism Spectrum Disorder
Actual Study Start Date :
Sep 26, 2022
Anticipated Primary Completion Date :
Sep 26, 2023
Anticipated Study Completion Date :
Sep 26, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Toddlers at elevated likelihood of developing autism with autistic signs, with early intervention

Toddlers at elevated likelihood of developing autism with clinical autistic signs who receive an early intervention from 18 to 24 months

Behavioral: Behavioral intervention based on Applied Behavior Analysis principles
Intervention sessions are conducted by licensed therapists with a training in applied behavior analysis or behavior analysts. One-to-one interventions for 3 h/week are carried out over a period of 5 months. The intervention focused on two target symptoms, imitation and joint attention, as two of the pivotal skills in early development. Behavior analytic techniques are used, including discrete trial, shaping for positive reinforcement, systematic prompting and fading procedures, and reinforcement procedures, according to the published manual. Imitation sessions start with imitation recognition and imitation of familiar actions (gestural and object imitation) and end with the imitation of novel actions. Joint attention evolvs from initiating requests (starting with gaze shift with the child looking away from an interesting object to the adult and back) to coordination of gaze shift, vocalization and gestures through reaching, and pointing and showing behaviors.

No Intervention: Toddlers at elevated likelihood of developing autism with autistic signs, without early intervention

Toddlers at elevated likelihood of developing autism with clinical autistic signs who do not receive an early intervention

No Intervention: Toddlers at elevated likelihood of developing autism without autistic signs who received monitoring

Toddlers at elevated likelihood of developing autism without clinical autistic signs who only received assessment and monitoring

No Intervention: Typically developing toddlers who received monitoring

Typically developing toddlers who only received assessment and monitoring

Outcome Measures

Primary Outcome Measures

  1. Change of electroencephalographic theta power (theta frequency band) [once at 18 months of age]

    Electroencephalographic theta power to synchronous/asynchronous social and nonsocial stimuli will be measured as an index of social and sensory processing in the 4 groups at T0 (18 months) and T1 (24 months). High-density 128 channel is recorded continuously throughout the session

  2. Change of electroencephalographic theta power (theta frequency band) [once at 24 months of age]

    Electroencephalographic theta power to synchronous/asynchronous social and nonsocial stimuli will be measured as an index of social and sensory processing in the 4 groups at T0 (18 months) and T1 (24 months). High-density 128 channel is recorded continuously throughout the session

  3. Change of looking behavior (time of fixations to Area of Interests) and pupillometry parameters (pupil diameter) [once at 18 months of age]

    Time of fixations (milliseconds) in different Areas of Interests (i.e., month and eyes) and pupil diameters (millimeters) will be recorded and analysed in the 4 groups at T0 (18 months) and T1 (24 months)

  4. Change of looking behavior (time of fixations to Area of Interests) and pupillometry parameters (pupil diameter) [once at 24 months of age]

    Time of fixations (milliseconds) in different Areas of Interests (i.e., month and eyes) and pupil diameters (millimeters) will be recorded and analysed in the 4 groups at T0 (18 months) and T1 (24 months)

Secondary Outcome Measures

  1. Change of standardized scores of clinical measures [Twice: at 18 and at 24 months of age]

    Standardized scores (i.e., z-scores, T-scores) of clinical tests (Griffiths Scales, Autism Diagnostic Observation Schedule-Second Edition, McArthur Questionnaire Sensory Profile) will be measured and will be correlated with electroencephalographic (theta power) and eyetracking (looking behavior and pupillometry parameters) data

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Months to 24 Months
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Toddlers aged between 18 and 24 months

  • Toddlers at elevated likelihood of developing autism, because siblings of children with a diagnosis of autism (for group 1, 2, and 3)

Exclusion Criteria:
  • Gestational age <36 weeks and/or birthweight < 2000 grams

  • Griffiths general quotient at 18 months < 70

  • presence of major complications in pregnancy and/or delivery likely to affect brain development

  • presence of neurological deficits, dysmorphic markers, or other medical conditions.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Associazione La Nostra Famiglia - IRCCS Eugenio Medea Bosisio Parini Lecco Italy 23842

Sponsors and Collaborators

  • IRCCS Eugenio Medea

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
IRCCS Eugenio Medea
ClinicalTrials.gov Identifier:
NCT05614206
Other Study ID Numbers:
  • 897
First Posted:
Nov 14, 2022
Last Update Posted:
Nov 14, 2022
Last Verified:
Nov 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by IRCCS Eugenio Medea
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 14, 2022